[Mutation of the FGFR3 oncogene is an independent and favorable prognostic factor for tumor-specific survival in patients with urothelial carcinoma of the upper urinary tract].

M. Bürger(Klinik und Poliklinik für Urologie), A Hartmann, Robert Stoehr(Friedrich-Alexander-Universität Erlangen-Nürnberg), Peter J. Wild(Goethe University Frankfurt), James W.F. Catto(University of Sheffield), Ellen C. Zwarthoff(Erasmus MC), Olivier Cussenot(Sorbonne Université), Johanna van Oers(Albert Einstein College of Medicine), A R Azzouri, M Meuth(University of Sheffield), Freddie C. Hamdy(University of Oxford)
PubMed
January 1, 2006
Cited by 14


Related Papers